Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Path2Quit Tobacco Intervention For African Americans

27 de marzo de 2019 actualizado por: Case Comprehensive Cancer Center

Development and Pilot Evaluation of the Path2Quit Tobacco Intervention Targeting African Americans

The purpose of this research is to study a smoking cessation program for adult smokers in Northeast Ohio. The study will also look at how different people respond to the program.

The study includes completing surveys and receiving text messages to help participants become tobacco free.

Descripción general del estudio

Estado

Terminado

Descripción detallada

OBJECTIVES Specific Aim 1: Translate a culturally specific video-based tobacco use intervention into a scalable mobile health (mhealth) format.

Specific Aim 2: Conduct a pilot study of the video-text intervention.

Study Design:

2-arm semi-pragmatic randomized design among current tobacco users

Cuyahoga Metropolitan Housing Authority residents will be randomly assigned to receive (1) the newly translated Path2Quit or (2) SmokeFreeText (NCI's publicly available, standard text messaging program) combined with brief behavioral counseling session plus 2 weeks of nicotine replacement therapy (NRT). Primary outcomes will include intervention evaluations (content and format), acceptability, coping strategies, engagement, and NRT adherence. Secondary variables will include 24-hour quit attempts and biochemically verified tobacco use abstinence at the 1-month follow-up. Exploratory mediational analyses will examine the roles of urban hassles, acculturation, neighborhood environment, ethnic discrimination, and psychological distress in intervention effects.

Tipo de estudio

Intervencionista

Inscripción (Actual)

119

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Ohio
      • Cleveland, Ohio, Estados Unidos, 44106
        • Case Western Reserve University, Case Comprehensive Cancer Center

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Self-identify as African American
  • Either smoke at least 1 cigarettes/day or have a carbon monoxide (CO) reading of at least 4 ppm
  • Consistent with SmokefreeTXT, be willing to set a quit date within the next 14 days.
  • Recruited from Cleveland metropolitan housing authority or who report low income based on federal guidelines

Exclusion Criteria:

  • Does not meet all of the above inclusion criteria

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Path2Quit
Culturally specific text message intervention
Path2Quit will deliver 20-60 second video clips by multimedia messaging service. The message library will include 75-170 messages. Written text messages will be limited to brief phrases to indicate the topic of the video. Messages will be pushed to participants in the morning, in the afternoon, and 2 hours before the reported usual bedtime. The cultural adaptations will be infused throughout the video segments. Topics include deep structure: race and smoking in general, African American smoking statistics; norms for smoking; concerns about nicotine replacement/medication; family/collectivism; unique stressors; racism/discrimination, depression; co-morbid addiction; neighborhood/environmental influences; menthol cigarettes; race-specific weight issues and concerns; and working as a community against the tobacco industry.
Comparador activo: SmokeFreeText
The National Cancer Institute's publicly available, standard text messaging program for tobacco cessation
SmokefreeTXT is a 6-8 week fully automated text-based cessation intervention. The program is free to U.S. subscribers who have a mobile phone, and is available on smokefree.gov or by texting "QUIT" to short code 47848. Participants are encouraged to set a quit date within the next 14 days, followed by count-down messages leading to the quit date. Starting on the quit date, participants receive 6 weeks of intervention text messages, and assessment questions (mood, cravings, smoking status). The message library contains 166 messages and 41 behavior change techniques,40 which are delivered at the greatest frequency during the first 2 weeks and taper over time. When in need of assistance, participants can text one of 3 keywords (MOOD, CRAVE, or SLIP) to receive a relevant message from the system. Participants can opt-out by texting STOP at any time. With informed consent, we will be able to access the SmokefreeTXT data for these participants.
Otros nombres:
  • SmokefreeTXT

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Proportion of participants who abstain from smoking
Periodo de tiempo: At 1-month follow-up
Abstinence will be coded as a binary variable. Analysis will be conducted with an intent to treat approach
At 1-month follow-up

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Number of missed nicotine replacement therapy doses
Periodo de tiempo: Up to 1-month follow-up
Measure of NRT adherence. Number of missed doses will be recorded for each participant
Up to 1-month follow-up
24-Hour quit attempts
Periodo de tiempo: At 1-month follow-up
Number of times a participant quits smoking for at least 24 hours
At 1-month follow-up
Changes in carbon monoxide breath levels from baseline to followup
Periodo de tiempo: At 1-month follow-up
Breath carbon monoxide tests will biochemically confirm self-reported cessation
At 1-month follow-up
Changes in Contemplation ladder score
Periodo de tiempo: From baseline to up to 1-month follow-up
self-reported score 0-10 where a higher score indicates more readiness to quit
From baseline to up to 1-month follow-up
Average score of Intervention Evaluation (IRQ)
Periodo de tiempo: At 1-month follow-up
The IRQ is a 22 item scale scored 0-7 (total score 0-154) where higher scores indicate more satisfaction
At 1-month follow-up
Average score of smoking urges
Periodo de tiempo: Up to 1-month follow-up
This brief, 10 item scale is scores 1-7 (total score 10-70) with higher scores indicating greater agreement
Up to 1-month follow-up

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Average scores of Urban hassles
Periodo de tiempo: Changes from baseline to 1 month follow-up
This is a 63 item scale scored 0-5 (total score 0-315) where higher scores indicate more severe hassle
Changes from baseline to 1 month follow-up
Average Neighborhood Environment scale score
Periodo de tiempo: At Baseline
The neighborhood environment scale is an 18 item True or False scale
At Baseline
Average General Ethnic Discrimination Scale Score
Periodo de tiempo: At baseline
This is a measure of ethnic discrimination. These 16 items are scored 1-6 (total score 16-96) with higher scores indicating greater levels of ethnic discrimination
At baseline
Average psychological distress score using the the perceived stress scale
Periodo de tiempo: At baseline
A ten item scale with each item scored 0-4 (total score 0-40) where higher scores indicate more stress. Positive items are scored in reverse.
At baseline
Average depression score using Center for Epidemiological Studies Depression (CES-D) Scale
Periodo de tiempo: At baseline
A twenty item scale ranging from 0-60 with each item scored 0-3. Higher scores indicate more depression
At baseline
Average Beliefs and Attitudes Survey Score
Periodo de tiempo: At baseline
This is a 24 item scale (total range 24-168) with each item scored 1-7. Higher scores indicate greater levels of agreement
At baseline
Average Ethnic Identity Score
Periodo de tiempo: At baseline
This is based on the Multigroup Ethnic Identity Measure scale. These five items are scored 1-4 for a total score of 5-20. Higher scores indicate stronger ethnic identity
At baseline
Average Culturally Specific Interventions Expectancy Questionnaire
Periodo de tiempo: At baseline
The Culturally Specific Interventions Expectancy Questionnaire is a 2 item scale with each item ranging 1-5 (total score 2-10) where higher scores indicate greater agreement.
At baseline

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Monica Webb Hooper, PhD, Case Comprehensive Cancer Center

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de abril de 2018

Finalización primaria (Actual)

20 de agosto de 2018

Finalización del estudio (Actual)

20 de agosto de 2018

Fechas de registro del estudio

Enviado por primera vez

30 de abril de 2018

Primero enviado que cumplió con los criterios de control de calidad

11 de mayo de 2018

Publicado por primera vez (Actual)

14 de mayo de 2018

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

28 de marzo de 2019

Última actualización enviada que cumplió con los criterios de control de calidad

27 de marzo de 2019

Última verificación

1 de marzo de 2019

Más información

Términos relacionados con este estudio

Palabras clave

Otros números de identificación del estudio

  • CASE1Y18

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir